LRRC24

Across TCGA pan-cancer cohorts, LRRC24 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LRRC24 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LRRC24 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LRRC24 expression acts as an unfavorable survival marker.

STAD, BLCA, and LIHC are the cancer types where LRRC24 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	II,III,IV	0.074	0.677	<.001	42	view →
BLCA	OS	Median	All	0.197	0.720	.004	18	view →
LIHC	OS	Median	All	0.172	0.779	<.001	15	view →
ACC	OS	Median	All	0.118	0.624	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LRRC24–STAD (OS)

Open the STAD breakdown →